Investor Relations
Latest Announcements
November 21, 2023 – Neogen to Participate in the Piper Sandler 35th Annual Healthcare Conference. David Naemura, Neogen’s Chief Financial Officer, will present at 1:30 p.m. Eastern Time on Thursday, November 30, 2023. Register for Webcast.
October 10, 2023 - Neogen Announces First-Quarter 2024 Results. Revenues for the first quarter were $229.0 million, an increase of 73.0% compared to $132.3 million in the prior year. Core revenue, which excludes the impacts of foreign currency translation, as well as acquisitions completed and product lines discontinued in the last 12 months, declined 1.3%. Acquisitions and discontinued product lines contributed 73.5% to revenue growth, while foreign currency added 0.8%.
August 31, 2023 – Neogen To Participate in 2023 Wells Fargo Healthcare Conference on Thursday, September 7. David Naemura, Neogen’s Chief Financial Officer, will present at 10:15 AM Eastern Time.
Latest Investor News
Revenues for the first quarter were $229.0 million, an increase of 73.0% compared to $132.3 million in the prior year.
The conference call can be accessed by dialing (844) 757-5681 (U.S.) or +1 (412) 317-5297 (international) and requesting the Neogen Corporation First Quarter 2024 Earnings Call (Conference ID: 10182677).
The fourth quarter marked the 124th of the past 130 quarters that Neogen reported revenue increases compared to the same quarter in the prior year.
Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.
John Adent, Neogen’s President and Chief Executive Officer, will present at 4:00 p.m. Central Time.
“The breadth of our product portfolio contributed to both legacy Neogen segments delivering quarterly core growth in a weaker end market environment,” said John Adent...
Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.
The second quarter marked the 122nd of the past 128 quarters that Neogen reported revenue increases compared to the same quarter in the prior year.
Forward Looking Statements
These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the company's most recently filed Form 10-K.